Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults

NCT05713760 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

NETWORK

Sponsor class

Conditions

Superficial Basal Cell Carcinoma

Interventions

DRUG: Tirbanibulin Ointment 1%

Sponsor

Austin Institute for Clinical Research